IL6R and plasma cell myeloma: These studies suggest a rapid, ligand-dependent interaction of CD45 with IL-6R complex and the physical association of CD45RO/RB with STAT3 may be potent ways of increasing the ability of IL-6-induced myeloma cells to proliferate.